PSORS1C2, psoriasis susceptibility 1 candidate 2, 170680
N. diseases: 16; N. variants: 14
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.160 | 6 | 31139481 | intron variant | T/C | snv | 0.72 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.810 | 1.000 | 2 | 2013 | 2014 | |||||||
|
1.000 | 0.040 | 6 | 31138491 | non coding transcript exon variant | A/C;G | snv | 8.1E-06; 0.33 |
|
Skin and Connective Tissue Diseases | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||||
|
6 | 31138682 | missense variant | C/A;T | snv | 0.13; 4.0E-06 |
|
0.700 | 1.000 | 3 | 2014 | 2019 | ||||||||||
|
1.000 | 0.040 | 6 | 31137370 | intron variant | C/T | snv |
|
Mental Disorders | 0.700 | 1.000 | 2 | 2017 | 2019 | ||||||||
|
1.000 | 0.120 | 6 | 31139956 | 3 prime UTR variant | C/T | snv | 0.23 | 0.21 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2007 | 2009 | ||||||
|
6 | 31140352 | upstream gene variant | C/T | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 6 | 31139410 | non coding transcript exon variant | G/A | snv | 0.25 |
|
Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 31139410 | non coding transcript exon variant | G/A | snv | 0.25 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.040 | 6 | 31137636 | 3 prime UTR variant | A/G | snv | 0.41 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.040 | 6 | 31137636 | 3 prime UTR variant | A/G | snv | 0.41 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 6 | 31137370 | intron variant | C/T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
6 | 31138829 | non coding transcript exon variant | A/T | snv | 0.14 | 0.11 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.040 | 6 | 31137856 | 3 prime UTR variant | C/G;T | snv |
|
Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.160 | 6 | 31139310 | non coding transcript exon variant | T/C | snv | 0.72 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.160 | 6 | 31140708 | upstream gene variant | G/A | snv | 0.71 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.080 | 6 | 31139278 | non coding transcript exon variant | C/T | snv | 9.3E-03 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 6 | 31139278 | non coding transcript exon variant | C/T | snv | 9.3E-03 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 6 | 31139278 | non coding transcript exon variant | C/T | snv | 9.3E-03 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 6 | 31139278 | non coding transcript exon variant | C/T | snv | 9.3E-03 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 6 | 31139278 | non coding transcript exon variant | C/T | snv | 9.3E-03 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 6 | 31139278 | non coding transcript exon variant | C/T | snv | 9.3E-03 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.160 | 6 | 31139481 | intron variant | T/C | snv | 0.72 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.040 | 6 | 31138722 | missense variant | G/A | snv | 0.11 | 0.14 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 |